Novartis India Ltd.

Novartis AG to sell its 70.68% stake in Novartis India Ltd to ChrysCapital group for around Rs 1,446 crore.

Novartis India stock jumps 20% after Novartis AG sells stake to ChrysCapital. Open offer for public shareholders announced.

Lupin receives USFDA approval for generic Siponimod tablets to treat multiple sclerosis. The drug will be manufactured in Pithampur.

Zetwerk names Jai Shankar Krishnan as Independent Director. Strengthens strategic depth & accelerates global expansion. Details inside.

Novartis India Ltd reports a 19% increase in net profit to Rs 24.22 crore for Q2 ended September 30, 2025. Revenue rises to Rs 90.33 crore.

Muthoot Fincorp announces Rs 4,000 cr IPO after doubling FY26 net profit. Stock split & NCD issuance also approved. Details here.

Vodafone Idea reports Rs 51,970 cr profit in Q4 FY26, its first in six years, due to reduced statutory liabilities (AGR).

Vodafone Idea plans to raise ₹4,730 crore from Aditya Birla Group via warrants. Capital infusion after AGR liability reduction.

Captain Polyplast begins production at its new Ahmedabad facility, boosting micro-irrigation systems capacity and in-house component manufacturing.

Delhivery reports Q4 profit of Rs 72.39 crore, a slight dip from last year, but income increases by 26%. FY26 consolidated PAT declines marginally.

India and Netherlands elevate relationship to strategic partnership. Modi and Jetten discuss trade, investment, and cooperation.

India and Netherlands elevate ties to a strategic partnership after talks between PM Modi and Dutch PM Rob Jetten. Key areas of cooperation highlighted.

PM Modi invites Dutch companies to design, innovate, and manufacture in India, highlighting opportunities in infrastructure, energy, and connectivity.

Muthoot Fincorp announces Rs 4,000 cr IPO after doubling FY26 net profit. Stock split & NCD issuance also approved. Details here.

Vodafone Idea reports Rs 51,970 cr profit in Q4 FY26, its first in six years, due to reduced statutory liabilities (AGR).